Integra Lifesciences reported $1.5B in Loan Capital for its second fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Loan Capital Change
Atricure ATRC:US USD 69.47M 89K
Baxter International BAX:US USD 16.15B 125M
Becton, Dickinson and BDX:US USD 13.89B 797M
Cooper Companies COO:US USD 2.35B 200K
Dexcom DXCM:US USD 2.03B 600K
Edwards Lifesciences EW:US USD 596.2M 200K
Hologic HOLX:US USD 2.81B 25.1M
Insulet PODD:US USD 1.38B 5.4M
Medtronic MDT:US USD 20.75B 3.27B
Merit Medical Systems MMSI:US USD 205.41M 30.29M
Nuvasive NUVA:US USD 444.35M 487K
Smith & Nephew PLC SN/:LN 2.28B 567M
Stryker SYK:US USD 12.75B 623M
Tandem Diabetes Care TNDM:US USD 282.79M 442K
Teleflex TFX:US USD 1.59B 12.45M
Zimmer Biomet Holdings Inc ZBH:US USD 5.06B 116.8M